G1 THERAPEUTICS, INC. Assets, Fair Value Disclosure
G1 THERAPEUTICS, INC. had Assets, Fair Value Disclosure of $60.75 million as of 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2024-08-08
- 2024-06-30: Assets, Fair Value Disclosure $60.75M.
- 2024-03-31: Assets, Fair Value Disclosure $65.00M.
- 2023-12-31: Assets, Fair Value Disclosure $82.05M.
- 2023-09-30: Assets, Fair Value Disclosure $94.04M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2024-06-30 | $60.75M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $65.00M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $82.05M 10-Q · filed 2024-08-08 |
| 2023-09-30 | $94.04M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $102.07M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $112.86M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $134.64M 10-K · filed 2024-02-28 |
| 2022-09-30 | $81.42M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $33.32M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $72.05M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $110.44M 10-K · filed 2023-03-01 |
| 2021-09-30 | $101.10M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $134.98M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $276.50M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $206.15M 10-K · filed 2022-02-23 |
| 2020-09-30 | $237.12M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $232.77M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $241.83M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $268.44M 10-K · filed 2021-02-24 |
| 2019-09-30 | $298.52M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $323.31M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $346.61M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $368.44M 10-K · filed 2020-02-26 |
| 2018-09-30 | $389.94M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $187.22M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $193.48M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $102.90M 10-K · filed 2019-02-28 |
| 2017-09-30 | $117.30M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $131.72M 10-Q · filed 2017-08-09 |
| 2016-12-31 | $46.77M 10-K · filed 2018-02-21 |